Ajith Athulya V, Khapre Meenakshi, Sinha Smita, Bairwa Mukesh, Srk Teja
Community Medicine and School of Public Health, Postgraduate Institute of Medical Education and Research, Chandigarh, IND.
Community and Family Medicine, All India Institute of Medical Sciences, Rishikesh, Rishikesh, IND.
Cureus. 2025 Apr 19;17(4):e82569. doi: 10.7759/cureus.82569. eCollection 2025 Apr.
INTRODUCTION: Late presentation to HIV care and delay of people living with HIV (PLHIV) linkage to ART continue to be a challenge in many countries of the world, including India. It has an adverse impact on the health of the patient and the outcome of antiretroviral therapy (ART) programs. In this study, we assessed the proportion of late presenters (LPs), factors associated with late presentation among PLHIV, and barriers to early presentation for HIV care among LPs in a tertiary center in India. METHODOLOGY: A sequential mixed-method study in which the quantitative part was conducted among 156 PLHIV receiving treatment at the ART center of All India Institute of Medical Sciences, Rishikesh, India. It was followed by a qualitative study with in-depth interviews of LPs. Continuous variables such as age and CD4 count were presented as median and interquartile range (IQR) and analyzed using the Mann-Whitney U test. Categorical variables such as gender, marital status, and probable mode of transmission, represented as frequency tables and proportions, were analyzed with Pearson's chi-square test or Fisher's exact test. A framework analysis with the help of social cognitive theory was conducted to analyze the barriers to presenting for HIV care. RESULT: The prevalence of late presentation to HIV care was 77.6%. The most probable mode of transmission was sexual contact among early and LPs. Age, marital status, and type of sexual contact were found to be associated with late presentation. The barriers to timely presentation for HIV care were identified as personal, behavioral, and environmental factors, which were interrelated. CONCLUSION: Regular testing of HIV in asymptomatic high-risk groups, extensive social and behavioral change communication to improve awareness, and new initiatives to sensitize healthcare professionals to enable them to provide better HIV care are necessary for the timely identification of PLHIV.
引言:在包括印度在内的世界许多国家,艾滋病毒感染者(PLHIV)接受艾滋病毒治疗过晚以及延迟接受抗逆转录病毒治疗(ART)仍然是一项挑战。这对患者健康和抗逆转录病毒治疗项目的结果产生不利影响。在本研究中,我们评估了印度一家三级中心中晚期就诊者(LP)的比例、PLHIV中与晚期就诊相关的因素以及晚期就诊者接受艾滋病毒治疗早期就诊的障碍。 方法:一项序贯混合方法研究,其中定量部分在印度瑞诗凯诗全印度医学科学研究所抗逆转录病毒治疗中心接受治疗的156名PLHIV中进行。随后对晚期就诊者进行深入访谈的定性研究。年龄和CD4计数等连续变量以中位数和四分位数间距(IQR)呈现,并使用曼-惠特尼U检验进行分析。性别、婚姻状况和可能的传播方式等分类变量以频率表和比例表示,使用Pearson卡方检验或Fisher精确检验进行分析。借助社会认知理论进行框架分析,以分析接受艾滋病毒治疗的障碍。 结果:艾滋病毒治疗晚期就诊的患病率为77.6%。早期就诊者和晚期就诊者中最可能的传播方式是性接触。发现年龄、婚姻状况和性接触类型与晚期就诊有关。接受艾滋病毒治疗及时就诊的障碍被确定为个人、行为和环境因素,这些因素相互关联。 结论:对无症状高危人群进行定期艾滋病毒检测、开展广泛的社会和行为改变宣传以提高认识,以及采取新举措提高医护人员的敏感性,使其能够提供更好的艾滋病毒治疗,对于及时识别PLHIV是必要的。
AIDS Res Treat. 2023-6-14
Int J Environ Res Public Health. 2022-4-11
Am J Trop Med Hyg. 2018-11
Medicine (Baltimore). 2016-9